These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2527995
1. Synthesis and biological evaluation of 4,6-diethyl-1,3,4,5-tetrahydropyrano[4,3-b]indole-4-acetic acid, an isomer of etodolac. Hughes P, DeVirgilio J, Humber LG, Chau T, Weichman B, Neuman G. J Med Chem; 1989 Sep; 32(9):2134-7. PubMed ID: 2527995 [Abstract] [Full Text] [Related]
2. Etodolac, a novel antiinflammatory agent. The syntheses and biological evaluation of its metabolites. Humber LG, Ferdinandi E, Demerson CA, Ahmed S, Shah U, Mobilio D, Sabatucci J, De Lange B, Labbadia F, Hughes P. J Med Chem; 1988 Sep; 31(9):1712-9. PubMed ID: 2970548 [Abstract] [Full Text] [Related]
3. Etodolic acid and related compounds. Chemistry and antiinflammatory actions of some potent di- and trisubstituted 1, 3, 4, 9-tetrahydropyrano[3, 4-b]indole-1-acetic acids. Martel RR, Demerson CA, Humber LG, Philipp AH. J Med Chem; 1976 Mar; 19(3):391-5. PubMed ID: 1255663 [Abstract] [Full Text] [Related]
4. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers. Demerson CA, Humber LG, Abraham NA, Schilling G, Martel RR, Pace-Asciak C. J Med Chem; 1983 Dec; 26(12):1778-80. PubMed ID: 6227748 [Abstract] [Full Text] [Related]
5. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer. Humber LG, Demerson CA, Swaminathan P, Bird PH. J Med Chem; 1986 May; 29(5):871-4. PubMed ID: 2939246 [Abstract] [Full Text] [Related]
6. Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels. Goldring MB, Sohbat E, Elwell JM, Chang JY. Eur J Rheumatol Inflamm; 1990 May; 10(1):10-21. PubMed ID: 2146129 [Abstract] [Full Text] [Related]
7. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions. Yoshida-Suzuka H, Nakamura Y, Shibata Y, Kimura K. Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269 [Abstract] [Full Text] [Related]
8. In vitro effects of Etodolac and acetylsalicylic acid on human chondrocyte metabolism. Henrotin Y, Bassleer C, Franchimont P. Agents Actions; 1992 Jul; 36(3-4):317-23. PubMed ID: 1388320 [Abstract] [Full Text] [Related]
9. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis. Taha AS, McLaughlin S, Holland PJ, Kelly RW, Sturrock RD, Russell RI. Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369 [Abstract] [Full Text] [Related]
10. Prostaglandins in inflammatory bone pathology: mechanism and therapeutic benefit of etodolac. Hayward MA, Howard GA, Neuman RG, Wood DD, Weichman BM, Van Sickle DC. Agents Actions; 1989 Mar; 26(3-4):310-8. PubMed ID: 2525314 [Abstract] [Full Text] [Related]
11. Effects of etodolac on human chondrocytes cultivated in three dimensional culture. Henrotin Y, Bassleer C, Reginster JY, Franchimont P. Clin Rheumatol; 1989 Mar; 8 Suppl 1():36-42. PubMed ID: 2545406 [Abstract] [Full Text] [Related]
12. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. II: Glycosaminoglycan synthesis. Redini F, Mauviel A, Loyau G, Pujol JP. Agents Actions; 1990 Nov; 31(3-4):358-67. PubMed ID: 2150741 [Abstract] [Full Text] [Related]
13. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Inoue K, Fujisawa H, Sasaki Y, Nishimura T, Nishimura I, Inoue Y, Yokota M, Masuda T, Ueda F, Shibata Y. Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085 [Abstract] [Full Text] [Related]
14. Modulation of extracellular matrix metabolism in rabbit articular chondrocytes and human rheumatoid synovial cells by the non-steroidal anti-inflammatory drug etodolac. I: Collagen synthesis. Mauviel A, Redini F, Loyau G, Pujol JP. Agents Actions; 1990 Nov; 31(3-4):345-52. PubMed ID: 2150740 [Abstract] [Full Text] [Related]
15. Etodolac and the treatment of arthritis. Scott DL. Eur J Rheumatol Inflamm; 1990 Nov; 10(1):1-2. PubMed ID: 2146128 [No Abstract] [Full Text] [Related]
16. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage. Weichman BM, Chau TT, Rona G. Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342 [Abstract] [Full Text] [Related]
17. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat. Lee DK, Chau TT, Weichman BM, Wooley PH. Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641 [Abstract] [Full Text] [Related]
18. [Chemical structure and anti-inflammatory activity in the group of substituted indole-3-acetic acids (author's transl)]. Boltze KH, Brendler O, Jacobi H, Opitz W, Raddatz S, Seidel PR, Vollbrecht D. Arzneimittelforschung; 1980 Mar; 30(8A):1314-25. PubMed ID: 7191301 [Abstract] [Full Text] [Related]
19. Etodolac: the role of a new NSAID in the management of arthritis and pain. Tenth Pan American Congress of Rheumatology and the Seventeenth Congress of the Mexican Society of Rheumatology. Guadalajara, Mexico, March 15, 1990. Rheumatol Int; 1990 Mar; 10 Suppl():1-34. PubMed ID: 1982022 [No Abstract] [Full Text] [Related]
20. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats. Ferdinandi ES, Cayen MN, Pace-Asciak C. J Pharmacol Exp Ther; 1982 Feb; 220(2):417-26. PubMed ID: 6460096 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]